The peptide was given the designation PL-10 and PL14736 during early clinical trial development by Pliva, a Croatian pharmaceutical company, specifically for inflammatory bowel disease
TB-500: What It Is and What It Isnt Online, TB-500 is usually described as a recovery peptide
Together, they offer a comprehensive model for studying accelerated recovery in vitro
(2019) Vitamin B12 intake from animal foods, biomarkers, and health aspects
The peptide also activates the FAK-paxillin pathway, important for cellular adhesion, migration, proliferation, and survival
While these studies explore a variety of biological pathways related to tissue response, angiogenesis, inflammation, and cellular behavior, the findings remain early-stage and model-specific